Preço Atual
$25.40
MOAT COMPETITIVO
↑Brand Recognition and Consumer Trust
Pfizer's name is synonymous with pharmaceuticals, fostering strong brand loyalty. This trust translates to preference for their products, even with generics available.
↑Extensive Research and Development Pipeline
Pfizer's massive R&D budget fuels a robust pipeline of potential blockbuster drugs. This continuous innovation protects market share and future revenue streams.
↑Global Distribution Network and Scale
Pfizer's established global network ensures efficient drug distribution. Their scale provides cost advantages and market access worldwide.
RISCOS DE INVESTIMENTO
↓Patent Expirations and Generic Competition
Loss of exclusivity on key drugs exposes Pfizer to generic erosion. Revenue declines significantly as cheaper alternatives enter the market.
↓Clinical Trial Failures and Regulatory Hurdles
Drug development is inherently risky, with potential for trial failures. Regulatory delays or rejections can significantly impact profitability.
↓Litigation and Product Liability
Pharmaceutical companies face potential lawsuits related to drug safety. Adverse events can lead to substantial financial penalties and reputational damage.
Combine insights de IA com valuation DCF ou PE para calcular o valor intrínseco. Tome decisões melhores baseadas em dados.
Esta página fornece insights de valuation com IA para Pfizer Inc. (PFE), incluindo moat competitivo e fatores de risco de investimento. O valuation é central para decisões de investimento sólidas — use as ferramentas de valuation DCF e PE do MiniValuator junto com estes insights de IA para calcular o valor intrínseco de PFE, margem de segurança, e chegar a um valuation bem fundamentado.
